Skip to main content
. 2023 Oct 23;31(1):614–621. doi: 10.1245/s10434-023-14422-2

Table 4.

Locations of recurrence

Recurrence after initial treatment (n = 192)
Location of recurrence (n, %)
 Peritoneum 41 (21.3%)
 Stomach 1 (0.5%)
 Small bowel 3 (1.5%)
 Colon 5 (2.6%)
 Mesentery 3 (1.5%)
 Pelvis 32 (16.7%)
 Incision/abdominal wall/umbilicus 16 (8.3%)
 Pancreas 1 (0.5%)
 Liver 4 (2.1%)
 Lymph nodes 4 (2.1%)
 Retroperitoneum 1 (0.5%)
 Chest 14 (7.3%)
 Multifocal 43 (22.4%)
 Unknown 24 (12.5%)